Table 3. Multivariate Cox regression analysis and hazard models of independent factors influencing overall- and disease-free survival in the entire study cohort (UICC I-IV) and early tumour stages (UICC I+II).
overall survival | disease-free survival | |||
---|---|---|---|---|
multivariate HR (95% CI) | P | multivariate HR (95% CI) | P | |
UICC I-IV | ||||
CK20 < 2.77 vs ≥ 2.77 [EU] | 2.49 (1.77 – 3.49) | <0.001 | 2.34 (1.69 – 3.22) | <0.001 |
age < 70 vs. ≥ 70 [years] | 1.27 (0.90 – 1,79) | 0.172 | n.d. | |
UICC I+II vs. III+IV | 7.85 (5.08 – 12.15) | <0.001 | 7.39 (4.90 – 11.16) | <0.001 |
adj. treatment yes vs. no | 1.10 (0.77 – 1.56) | 0.610 | 1.09 (0.78 – 1.53) | 0.606 |
UICC I+II | ||||
CK20 < 2.77 vs. ≥ 2.77 [EU] | 2.25 (1.06 – 4.77) | 0.035 | 2.01 (1.01 – 4.01) | 0.047 |
age < 70 vs. ≥ 70 [years] | 1.59 (0.73 – 3.47) | 0.245 | n.d. | |
colon vs. rectum | 0.22 (0.09 – 0.50) | <0.001 | 0.27 (0.13 – 0.57) | 0.001 |
pT1/2 vs. pT3/4 | 4.50 (1.99 – 10.17) | <0.001 | 4.17 (1.97 – 8.85) | <0.001 |
All P values in bold, are regarded as statistically significant; n.d.: the value was not significant in univariate analysis and therefore not considered in multivariate analysis; HR: hazard ratio, CI: confidence interval; CK20: cytokeratin 20; EU: expression units.